Risk of suicidality in mental and neurological disorders in low and middle-income countries: A systematic review and meta-analysis.

Journal: Comprehensive psychiatry

Volume: 123

Issue: 

Year of Publication: 2023

Affiliated Institutions:  Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. Electronic address: longeri@kemri.go.ke. Neuroscience Unit, Kenya Medical Research Institute-Wellcome Trust Research Program, Kilifi, Kenya. Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands. Department of Ethics, Law and Humanities, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Neuroscience Unit, Kenya Medical Research Institute-Wellcome Trust Research Program, Kilifi, Kenya; Department of Public Health, Pwani University, Kilifi, Kenya. Neuroscience Unit, Kenya Medical Research Institute-Wellcome Trust Research Program, Kilifi, Kenya; Department of Psychiatry, University of Oxford, United Kingdom.

Abstract summary 

Both fatal and nonfatal suicidal behaviours are important complications of mental, neurological, and substance use disorders (MNSDs) worldwide. We aimed at quantifying the association of suicidal behaviour with MNSDs in Low and Middle Income Countries (LMICs) where varying environmental and socio-cultural factors may impact outcome.We conducted a systematic review and meta-analysis to report the associations between MNSDs and suicidality in LMICs and the study-level factors of these associations. We searched the following electronic databases: PUBMED, PsycINFO, MEDLINE, CINAHL, World Cat, and Cochrane library for studies on suicide risk in MNSDs, with a comparison/control group of persons without MNSDs, published from January 1, 1995 to September 3, 2020. Median estimates were calculated for relative risks for suicide behaviour and MNSDs, and when appropriate, these were pooled using random effects metanalytic model. This study was registered with PROSPERO, CRD42020178772.The search identified 73 eligible studies: 28 were used for quantitative synthesis of estimates and 45 for description of risk factors. Studies included came from low and upper middle-income countries with a majority of these from Asia and South America and none from a low-income country. The sample size was 13,759 for MNSD cases and 11,792 hospital or community controls without MNSD. The most common MNSD exposure for suicidal behaviour was depressive disorders (47 studies (64%)), followed by schizophrenia spectrum, and other psychotic disorders (28 studies (38%)). Pooled estimates from the meta-analysis were statistically significant for suicidal behaviour with any MNSDs (odds ratios (OR) = 1∙98 (95%CI = 1∙80-2∙16))) and depressive disorder (OR = 3∙26 (95%CI = 2∙88-3∙63))), with both remaining significant after inclusion of high-quality studies only. Meta-regression identified only hospital-based studies (ratio of OR = 2∙85, CI:1∙24-6∙55) and sample size (OR = 1∙00, CI:0∙99-1∙00) as possible sources of variability in estimates. Risk for suicidal behaviour in MNSDs was increased by demographic factors (e.g., male sex, and unemployment), family history, psychosocial context and physical illness.There is an association between suicidal behaviour and MNSDs in LMICs, the association is greater for depressive disorder in LMICs than what has been reported in High Income Countries (HICs). There is urgent need to improve access for MNSDs care in LMICs.None.

Authors & Co-authors:  Ongeri Theuri Nyawira Penninx Tijdink Kariuki Newton

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  7
Identifiers
Doi : 10.1016/j.comppsych.2023.152382
SSN : 1532-8384
Study Population
Male
Mesh Terms
Humans
Other Terms
LMICs;Mental neurological and substance use disorders;Suicide;Systematic review
Study Design
Study Approach
Quantitative
Country of Study
Kenya
Publication Country
United States